Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has completed inspection at Concord Biotech’s Unit II (formulation facility), located at Valthera-Dholka in Ahmedabad, Gujarat. The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on February 22, 2024.
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
